Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Antidepressant Learning Disability and Autism | antidepressant-prescribing-lda | 10033 | TPP | 1/1 | Christine Cunningham | 3 years, 8 months ago 07 July 2022 11:56:42 UTC | View, Job request 10033 |
| Succeeded | Antidepressant Learning Disability and Autism | antidepressant-prescribing-lda | 10029 | TPP | 1/1 | Christine Cunningham | 3 years, 8 months ago 07 July 2022 11:12:14 UTC | View, Job request 10029 |
| Succeeded | Antidepressant Learning Disability and Autism | antidepressant-prescribing-lda | 10028 | TPP | 1/1 | Christine Cunningham | 3 years, 8 months ago 07 July 2022 09:55:56 UTC | View, Job request 10028 |
| Failed | COVID-19 Vaccine Effectiveness | comparative-booster_main | 10016 | TPP | 3/21 | Will Hulme | 3 years, 8 months ago 07 July 2022 12:20:03 UTC | View, Job request 10016 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 10013 | TPP | 0/1 | Bang Zheng | 3 years, 8 months ago 07 July 2022 12:20:20 UTC | View, Job request 10013 |
| Failed | Covid-19 related death over time | covid_mortality_over_time | 10012 | TPP | 0/22 | Linda Nab | 3 years, 8 months ago 07 July 2022 12:20:04 UTC | View, Job request 10012 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-report | 9959 | TPP | 6/6 | Linda Nab | 3 years, 8 months ago 07 July 2022 12:20:49 UTC | View, Job request 9959 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mab-av-non-user-main | 9958 | TPP | 1/1 | Linda Nab | 3 years, 8 months ago 07 July 2022 12:20:01 UTC | View, Job request 9958 |
| Succeeded | OpenSAFELY Interactive | opensafely-interactive | 9957 | TPP | 4/4 | OpenSAFELY Interactive | 3 years, 8 months ago 07 July 2022 12:20:17 UTC | View, Job request 9957 |
| Failed | OpenSAFELY Interactive | opensafely-interactive | 9948 | TPP | 0/1 | OpenSAFELY Interactive | 3 years, 8 months ago 04 July 2022 11:14:35 UTC | View, Job request 9948 |
| Failed | OpenSAFELY Interactive | opensafely-interactive | 9947 | TPP | 0/1 | OpenSAFELY Interactive | 3 years, 8 months ago 04 July 2022 11:14:42 UTC | View, Job request 9947 |
| Failed | OpenSAFELY Interactive | opensafely-interactive | 9946 | TPP | 0/1 | OpenSAFELY Interactive | 3 years, 8 months ago 04 July 2022 11:14:44 UTC | View, Job request 9946 |
| Failed | OpenSAFELY Interactive | opensafely-interactive | 9945 | TPP | 0/1 | OpenSAFELY Interactive | 3 years, 8 months ago 04 July 2022 11:14:56 UTC | View, Job request 9945 |
| Succeeded | Trends and clinical characteristics of COVID-19 vaccine recipients | covid-vaccine-preliminary-study-master | 9943 | TPP | 1/1 | Lisa Hopcroft | 3 years, 8 months ago 30 June 2022 10:22:21 UTC | View, Job request 9943 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-sgtf | 9908 | TPP | 1/1 | Millie Green | 3 years, 8 months ago 29 June 2022 14:10:23 UTC | View, Job request 9908 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-sgtf | 9902 | TPP | 1/1 | Millie Green | 3 years, 8 months ago 29 June 2022 13:49:27 UTC | View, Job request 9902 |
| Succeeded | Trends and clinical characteristics of COVID-19 vaccine recipients | covid-vaccine-preliminary-study-master | 9901 | TPP | 2/2 | Lisa Hopcroft | 3 years, 8 months ago 29 June 2022 13:48:04 UTC | View, Job request 9901 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-sgtf | 9899 | TPP | 1/1 | Millie Green | 3 years, 8 months ago 29 June 2022 13:39:32 UTC | View, Job request 9899 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-sgtf | 9895 | TPP | 1/1 | Millie Green | 3 years, 8 months ago 29 June 2022 13:25:01 UTC | View, Job request 9895 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-sgtf | 9893 | TPP | 1/1 | Millie Green | 3 years, 8 months ago 29 June 2022 13:10:23 UTC | View, Job request 9893 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-sgtf | 9890 | TPP | 1/1 | Millie Green | 3 years, 8 months ago 29 June 2022 12:52:13 UTC | View, Job request 9890 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-sgtf | 9889 | TPP | 1/1 | Millie Green | 3 years, 8 months ago 29 June 2022 12:38:09 UTC | View, Job request 9889 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-sgtf | 9887 | TPP | 1/1 | Millie Green | 3 years, 8 months ago 29 June 2022 12:28:45 UTC | View, Job request 9887 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | mabs-sgtf | 9885 | TPP | 2/2 | Millie Green | 3 years, 8 months ago 29 June 2022 11:44:08 UTC | View, Job request 9885 |
| Succeeded | Pathology-comparators-short-report | pathology-comparators-main | 9881 | TPP | 1/1 | Helen Curtis | 3 years, 8 months ago 29 June 2022 10:53:07 UTC | View, Job request 9881 |